1
UNITEDHEALTH GROUP INC
COM
UNH
UNH
93,600
$38.9m3.67%
3.67%
Added Shares held: Q3 2025 62.5k, Q4 2025 54.9k, Q1 2026 45.5k, Q2 2026 93.6k
+48.1k
+48,100
105.7%
2
CVS HEALTH CORP
COM
CVS
CVS
279,374
$28.9m2.73%
2.73%
Reduced Shares held: Q3 2025 277.4k, Q4 2025 335.5k, Q1 2026 336.5k, Q2 2026 279.4k
-57.1k
-57,126
-17.0%
3
ASTRAZENECA PLC
ORD
AZN
AZN
151,500
$28.5m2.69%
2.69%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 151.5k
4
MERCK & CO INC
COM
MRK
MRK
213,500
$27.4m2.59%
2.59%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 213.5k
5
ELI LILLY & CO
COM
LLY
LLY
22,315
$26.8m2.53%
2.53%
Reduced Shares held: Q3 2025 53.4k, Q4 2025 42.2k, Q1 2026 33.7k, Q2 2026 22.3k
-11.4k
-11,400
-33.8%
6
ABBVIE INC
COM
ABBV
ABBV
96,775
$24.4m2.30%
2.30%
Added Shares held: Q3 2025 130.4k, Q4 2025 110.6k, Q1 2026 71.6k, Q2 2026 96.8k
+25.2k
+25,200
35.2%
7
ALIGNMENT HEALTHCARE INC
COM
ALHC
ALHC
997,083
$23.7m2.24%
2.24%
Reduced Shares held: Q3 2025 1.5m, Q4 2025 1.0m, Q1 2026 1.1m, Q2 2026 997.1k
-56.4k
-56,367
-5.3%
8
EDWARDS LIFESCIENCES CORP
COM
EW
EW
260,000
$23.5m2.22%
2.22%
Added Shares held: Q3 2025 155.0k, Q4 2025 193.5k, Q1 2026 163.0k, Q2 2026 260.0k
+97.0k
+97,000
59.5%
9
GILEAD SCIENCES INC
COM
GILD
GILD
178,250
$22.5m2.13%
2.13%
Added Shares held: Q3 2025 80.2k, Q4 2025 126.2k, Q1 2026 167.8k, Q2 2026 178.2k
+10.5k
+10,500
6.3%
10
JAZZ PHARMACEUTICALS PLC
SHS USD
JAZZ
JAZZ
87,440
$21.1m1.99%
1.99%
Added Shares held: Q3 2025 95.0k, Q4 2025 74.0k, Q1 2026 75.9k, Q2 2026 87.4k
+11.6k
+11,550
15.2%
11
BIOGEN INC
COM
BIIB
BIIB
94,850
$20.5m1.93%
1.93%
Reduced Shares held: Q3 2025 55.0k, Q4 2025 92.3k, Q1 2026 109.1k, Q2 2026 94.8k
-14.2k
-14,250
-13.1%
12
STRYKER CORPORATION
COM
SYK
SYK
65,000
$20.5m1.93%
1.93%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 47.8k, Q2 2026 65.0k
+17.2k
+17,200
36.0%
13
BOSTON SCIENTIFIC CORP
COM
BSX
BSX
450,500
$19.2m1.81%
1.81%
Reduced Shares held: Q3 2025 438.0k, Q4 2025 431.2k, Q1 2026 625.0k, Q2 2026 450.5k
-174.5k
-174,500
-27.9%
14
JOHNSON & JOHNSON
COM
JNJ
JNJ
72,500
$18.4m1.74%
1.74%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 72.5k
15
GUARDANT HEALTH INC
COM
GH
GH
115,000
$17.3m1.63%
1.63%
Reduced Shares held: Q3 2025 50.0k, Q4 2025 80.0k, Q1 2026 145.0k, Q2 2026 115.0k
-30.0k
-30,000
-20.7%
16
REGENERON PHARMACEUTICALS
COM
REGN
REGN
27,390
$17.1m1.61%
1.61%
Reduced Shares held: Q3 2025 36.1k, Q4 2025 61.4k, Q1 2026 48.1k, Q2 2026 27.4k
-20.7k
-20,710
-43.1%
17
GLAUKOS CORP
COM
GKOS
GKOS
119,000
$16.6m1.57%
1.57%
Added Shares held: Q3 2025 230.0k, Q4 2025 210.0k, Q1 2026 84.0k, Q2 2026 119.0k
+35.0k
+35,000
41.7%
18
BIOMARIN PHARMACEUTICAL INC
COM
BMRN
BMRN
290,500
$16.6m1.57%
1.57%
Added Shares held: Q3 2025 186.7k, Q4 2025 215.0k, Q1 2026 207.0k, Q2 2026 290.5k
+83.5k
+83,500
40.3%
19
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
684,250
$16.6m1.57%
1.57%
Added Shares held: Q3 2025 347.5k, Q4 2025 537.5k, Q1 2026 313.5k, Q2 2026 684.2k
+370.8k
+370,750
118.3%
20
NATERA INC
COM
NTRA
NTRA
61,050
$16.6m1.56%
1.56%
Added Shares held: Q3 2025 31.0k, Q4 2025 40.5k, Q1 2026 51.6k, Q2 2026 61.0k
+9.4k
+9,450
18.3%
21
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
139,205
$16.3m1.54%
1.54%
Added Shares held: Q3 2025 56.3k, Q4 2025 106.3k, Q1 2026 92.6k, Q2 2026 139.2k
+46.6k
+46,600
50.3%
22
INSMED INC
COM PAR $.01
INSM
INSM
151,960
$16.2m1.53%
1.53%
Reduced Shares held: Q3 2025 131.9k, Q4 2025 113.6k, Q1 2026 159.8k, Q2 2026 152.0k
-7.8k
-7,800
-4.9%
23
TENET HEALTHCARE CORP
COM NEW
THC
THC
85,200
$15.9m1.50%
1.50%
Added Shares held: Q3 2025 58.4k, Q4 2025 76.5k, Q1 2026 54.0k, Q2 2026 85.2k
+31.2k
+31,200
57.8%
24
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
31,580
$15.8m1.49%
1.49%
Reduced Shares held: Q3 2025 30.0k, Q4 2025 33.6k, Q1 2026 41.3k, Q2 2026 31.6k
-9.8k
-9,760
-23.6%
25
CENTENE CORP DEL
COM
CNC
CNC
244,000
$15.7m1.48%
1.48%
New Shares held: Q3 2025 170.0k, Q4 2025 46.2k, Q1 2026 0, Q2 2026 244.0k
26
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
63,050
$15.4m1.46%
1.46%
Reduced Shares held: Q3 2025 172.8k, Q4 2025 114.8k, Q1 2026 63.8k, Q2 2026 63.0k
-750
-750
-1.2%
27
DANAHER CORPORATION
COM
DHR
DHR
80,252
$15.3m1.44%
1.44%
Added Shares held: Q3 2025 134.5k, Q4 2025 99.1k, Q1 2026 18.1k, Q2 2026 80.3k
+62.2k
+62,200
344.6%
28
VERTEX PHARMACEUTICALS INC
COM
VRTX
VRTX
30,685
$15.2m1.44%
1.44%
Reduced Shares held: Q3 2025 47.0k, Q4 2025 34.3k, Q1 2026 43.5k, Q2 2026 30.7k
-12.8k
-12,800
-29.4%
29
ANTERIS TECHNOLOGIES GLOBAL
COM
AVR
AVR
1,538,625
$15.2m1.43%
1.43%
Added Shares held: Q3 2025 1.3m, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 1.5m
+100.0k
+100,000
7.0%
30
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
85,841
$14.5m1.37%
1.37%
Reduced Shares held: Q3 2025 114.7k, Q4 2025 125.5k, Q1 2026 100.8k, Q2 2026 85.8k
-15.0k
-15,000
-14.9%
31
PENNANT GROUP INC
COM
PNTG
PNTG
371,471
$13.7m1.30%
1.30%
Added Shares held: Q3 2025 0, Q4 2025 357.3k, Q1 2026 275.4k, Q2 2026 371.5k
+96.1k
+96,072
34.9%
32
INTUITIVE SURGICAL INC
COM NEW
ISRG
ISRG
34,500
$13.7m1.30%
1.30%
Reduced Shares held: Q3 2025 48.5k, Q4 2025 48.0k, Q1 2026 36.8k, Q2 2026 34.5k
-2.3k
-2,346
-6.4%
33
ELEVANCE HEALTH INC
COM
ELV
ELV
34,900
$13.5m1.27%
1.27%
Added Shares held: Q3 2025 22.5k, Q4 2025 15.0k, Q1 2026 32.3k, Q2 2026 34.9k
+2.6k
+2,600
8.1%
34
LIVANOVA PLC
SHS
LIVN
LIVN
164,000
$13.5m1.27%
1.27%
Added Shares held: Q3 2025 53.0k, Q4 2025 190.0k, Q1 2026 155.0k, Q2 2026 164.0k
+9.0k
+9,000
5.8%
35
CENCORA INC
COM
COR
COR
46,778
$13.2m1.25%
1.25%
Reduced Shares held: Q3 2025 62.4k, Q4 2025 63.4k, Q1 2026 52.4k, Q2 2026 46.8k
-5.6k
-5,597
-10.7%
36
CHARLES RIV LABS INTL INC
COM
CRL
CRL
57,200
$13.0m1.22%
1.22%
Added Shares held: Q3 2025 0, Q4 2025 22.0k, Q1 2026 26.0k, Q2 2026 57.2k
+31.2k
+31,200
120.0%
37
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
343,800
$12.8m1.21%
1.21%
Added Shares held: Q3 2025 0, Q4 2025 250.0k, Q1 2026 255.5k, Q2 2026 343.8k
+88.3k
+88,300
34.6%
38
MCKESSON CORP
COM
MCK
MCK
16,550
$12.5m1.18%
1.18%
Reduced Shares held: Q3 2025 26.6k, Q4 2025 25.6k, Q1 2026 16.9k, Q2 2026 16.6k
-300
-300
-1.8%
39
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
560,250
$12.2m1.16%
1.16%
Added Shares held: Q3 2025 574.0k, Q4 2025 487.0k, Q1 2026 379.2k, Q2 2026 560.2k
+181.0k
+181,000
47.7%
40
BRIGHTSPRING HEALTH SVCS INC
COM
BTSG
BTSG
165,896
$11.6m1.09%
1.09%
Added Shares held: Q3 2025 60.0k, Q4 2025 198.0k, Q1 2026 50.0k, Q2 2026 165.9k
+115.9k
+115,896
231.8%
41
MEDTRONIC PLC
SHS
MDT
MDT
145,000
$11.3m1.07%
1.07%
Added Shares held: Q3 2025 205.0k, Q4 2025 296.0k, Q1 2026 90.0k, Q2 2026 145.0k
+55.0k
+55,000
61.1%
42
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
416,371
$11.2m1.06%
1.06%
Added Shares held: Q3 2025 165.0k, Q4 2025 142.6k, Q1 2026 263.1k, Q2 2026 416.4k
+153.3k
+153,300
58.3%
43
OSCAR HEALTH INC
CL A
OSCR
OSCR
392,000
$11.2m1.06%
1.06%
Reduced Shares held: Q3 2025 0, Q4 2025 260.0k, Q1 2026 660.0k, Q2 2026 392.0k
-268.0k
-268,000
-40.6%
44
ROYALTY PHARMA PLC
SHS CLASS A
RPRX
RPRX
197,000
$11.0m1.04%
1.04%
Reduced Shares held: Q3 2025 258.5k, Q4 2025 206.5k, Q1 2026 233.0k, Q2 2026 197.0k
-36.0k
-36,000
-15.4%
45
DEXCOM INC
COM
DXCM
DXCM
160,000
$10.8m1.02%
1.02%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 160.0k
46
ALIGN TECHNOLOGY INC
COM
ALGN
ALGN
63,000
$10.6m1.00%
1.00%
Added Shares held: Q3 2025 83.0k, Q4 2025 99.0k, Q1 2026 7.5k, Q2 2026 63.0k
+55.5k
+55,500
740.0%
47
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
119,300
$10.6m1.00%
1.00%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 119.3k
48
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
566,000
$10.6m1.00%
1.00%
Added Shares held: Q3 2025 460.0k, Q4 2025 460.0k, Q1 2026 360.0k, Q2 2026 566.0k
+206.0k
+206,000
57.2%
49
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
128,000
$10.4m0.98%
0.98%
Reduced Shares held: Q3 2025 0, Q4 2025 144.5k, Q1 2026 144.5k, Q2 2026 128.0k
-16.5k
-16,500
-11.4%
50
AGILENT TECHNOLOGIES INC
COM
A
A
75,000
$10.0m0.94%
0.94%
Added Shares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 25.0k, Q2 2026 75.0k
+50.0k
+50,000
200.0%
51
NEKTAR THERAPEUTICS
COM NEW
NKTR
NKTR
141,250
$9.9m0.93%
0.93%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 59.0k, Q2 2026 141.2k
+82.2k
+82,250
139.4%
52
ALKERMES PLC
SHS
ALKS
ALKS
185,250
$9.7m0.92%
0.92%
Added Shares held: Q3 2025 94.0k, Q4 2025 133.2k, Q1 2026 133.2k, Q2 2026 185.2k
+52.0k
+52,000
39.0%
53
ABBOTT LABS
COM
ABT
ABT
96,000
$8.7m0.82%
0.82%
Reduced Shares held: Q3 2025 98.5k, Q4 2025 0, Q1 2026 112.0k, Q2 2026 96.0k
-16.0k
-16,000
-14.3%
54
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
86,127
$8.4m0.79%
0.79%
Added Shares held: Q3 2025 173.6k, Q4 2025 98.6k, Q1 2026 81.6k, Q2 2026 86.1k
+4.5k
+4,500
5.5%
55
PROCEPT BIOROBOTICS CORP
COM
PRCT
PRCT
345,000
$7.8m0.74%
0.74%
Reduced Shares held: Q3 2025 390.0k, Q4 2025 611.0k, Q1 2026 475.0k, Q2 2026 345.0k
-130.0k
-130,000
-27.4%
56
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
145,100
$7.8m0.74%
0.74%
Added Shares held: Q3 2025 180.1k, Q4 2025 147.6k, Q1 2026 128.1k, Q2 2026 145.1k
+17.0k
+17,000
13.3%
57
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
80,000
$7.6m0.72%
0.72%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
58
ENCOMPASS HEALTH CORP
COM
EHC
EHC
74,263
$7.5m0.71%
0.71%
Added Shares held: Q3 2025 119.4k, Q4 2025 146.3k, Q1 2026 56.3k, Q2 2026 74.3k
+18.0k
+18,000
32.0%
59
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
384,800
$7.5m0.71%
0.71%
Added Shares held: Q3 2025 207.0k, Q4 2025 364.0k, Q1 2026 239.5k, Q2 2026 384.8k
+145.3k
+145,300
60.7%
60
IOVANCE BIOTHERAPEUTICS INC
COM
IOVA
IOVA
1,705,327
$7.1m0.67%
0.67%
Reduced Shares held: Q3 2025 1.1m, Q4 2025 1.6m, Q1 2026 2.1m, Q2 2026 1.7m
-350.0k
-350,000
-17.0%
61
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
91,100
$6.8m0.64%
0.64%
Added Shares held: Q3 2025 0, Q4 2025 81.6k, Q1 2026 90.6k, Q2 2026 91.1k
+500
+500
0.6%
62
KURA ONCOLOGY INC
COM
KURA
KURA
591,500
$6.5m0.61%
0.61%
Added Shares held: Q3 2025 490.0k, Q4 2025 872.0k, Q1 2026 271.5k, Q2 2026 591.5k
+320.0k
+320,000
117.9%
63
INSULET CORP
COM
PODD
PODD
42,000
$6.4m0.60%
0.60%
Added Shares held: Q3 2025 58.0k, Q4 2025 61.0k, Q1 2026 14.0k, Q2 2026 42.0k
+28.0k
+28,000
200.0%
64
ERASCA INC
COM
ERAS
ERAS
349,000
$6.4m0.60%
0.60%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 349.0k
65
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
16,325
$6.1m0.57%
0.57%
Reduced Shares held: Q3 2025 11.8k, Q4 2025 25.0k, Q1 2026 16.7k, Q2 2026 16.3k
-350
-350
-2.1%
66
STEVANATO GROUP S P A
ORD SHS
STVN
STVN
305,972
$5.5m0.52%
0.52%
Added Shares held: Q3 2025 51.0k, Q4 2025 147.0k, Q1 2026 274.7k, Q2 2026 306.0k
+31.3k
+31,296
11.4%
67
ASTRANA HEALTH INC
COM NEW
ASTH
ASTH
118,888
$5.5m0.52%
0.52%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 118.9k
68
CARDINAL HEALTH INC
COM
CAH
CAH
22,500
$5.3m0.50%
0.50%
Reduced Shares held: Q3 2025 94.0k, Q4 2025 0, Q1 2026 27.0k, Q2 2026 22.5k
-4.5k
-4,500
-16.7%
69
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
17,200
$5.2m0.49%
0.49%
Reduced Shares held: Q3 2025 31.9k, Q4 2025 45.7k, Q1 2026 34.5k, Q2 2026 17.2k
-17.3k
-17,265
-50.1%
70
MOLINA HEALTHCARE INC
COM
MOH
MOH
21,857
$5.0m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.9k
71
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
128,000
$5.0m0.47%
0.47%
Reduced Shares held: Q3 2025 216.3k, Q4 2025 83.0k, Q1 2026 160.0k, Q2 2026 128.0k
-32.0k
-32,000
-20.0%
72
THE CIGNA GROUP
COM
CI
CI
17,400
$4.8m0.45%
0.45%
Added Shares held: Q3 2025 46.5k, Q4 2025 38.6k, Q1 2026 8.0k, Q2 2026 17.4k
+9.4k
+9,400
117.5%
73
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
59,900
$4.7m0.45%
0.45%
Reduced Shares held: Q3 2025 310.0k, Q4 2025 158.5k, Q1 2026 92.9k, Q2 2026 59.9k
-33.0k
-33,000
-35.5%
74
AMN HEALTHCARE SVCS INC
COM
AMN
AMN
144,466
$4.7m0.44%
0.44%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 144.5k
75
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
179,000
$4.6m0.43%
0.43%
Reduced Shares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 199.0k, Q2 2026 179.0k
-20.0k
-20,000
-10.1%
76
MEDPACE HLDGS INC
COM
MEDP
MEDP
8,500
$4.5m0.42%
0.42%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.5k
77
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
8,050
$4.3m0.41%
0.41%
Reduced Shares held: Q3 2025 18.2k, Q4 2025 19.6k, Q1 2026 24.1k, Q2 2026 8.1k
-16.0k
-16,000
-66.5%
78
AMGEN INC
COM
AMGN
AMGN
11,900
$4.3m0.41%
0.41%
Reduced Shares held: Q3 2025 0, Q4 2025 36.0k, Q1 2026 15.2k, Q2 2026 11.9k
-3.3k
-3,300
-21.7%
79
SIONNA THERAPEUTICS INC
COM
SION
SION
97,100
$4.3m0.40%
0.40%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 87.5k, Q2 2026 97.1k
+9.6k
+9,600
11.0%
80
ASCENDIS PHARMA A/S
ORD SHS
ASND
ASND
15,000
$4.0m0.38%
0.38%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.0k
81
COOPER COS INC
COM
COO
COO
54,000
$3.9m0.37%
0.37%
Added Shares held: Q3 2025 237.0k, Q4 2025 327.5k, Q1 2026 50.0k, Q2 2026 54.0k
+4.0k
+4,000
8.0%
82
WAYSTAR HLDG CORP
COM
WAY
WAY
178,566
$3.7m0.35%
0.35%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 342.6k, Q2 2026 178.6k
-164.0k
-164,000
-47.9%
83
MBX BIOSCIENCES INC
COM
MBX
MBX
62,000
$3.4m0.32%
0.32%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 62.0k
84
VERICEL CORP
COM
VCEL
VCEL
70,000
$3.1m0.29%
0.29%
Unchanged Shares held: Q3 2025 117.0k, Q4 2025 117.0k, Q1 2026 70.0k, Q2 2026 70.0k
85
VEEVA SYS INC
CL A COM
VEEV
VEEV
17,300
$3.1m0.29%
0.29%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 85.3k, Q2 2026 17.3k
-68.0k
-68,000
-79.7%
86
BICARA THERAPEUTICS INC
COM
BCAX
BCAX
88,150
$2.6m0.25%
0.25%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 88.2k
87
STERIS PLC
SHS USD
STE
STE
11,500
$2.4m0.23%
0.23%
Unchanged Shares held: Q3 2025 0, Q4 2025 6.0k, Q1 2026 11.5k, Q2 2026 11.5k
88
OCULAR THERAPEUTIX INC
COM
OCUL
OCUL
225,000
$2.2m0.21%
0.21%
Reduced Shares held: Q3 2025 202.0k, Q4 2025 265.0k, Q1 2026 305.0k, Q2 2026 225.0k
-80.0k
-80,000
-26.2%
89
STOKE THERAPEUTICS INC
COM
STOK
STOK
64,500
$2.1m0.20%
0.20%
Reduced Shares held: Q3 2025 250.0k, Q4 2025 216.0k, Q1 2026 83.0k, Q2 2026 64.5k
-18.5k
-18,500
-22.3%
90
XENON PHARMACEUTICALS INC
COM
XENE
XENE
33,250
$2.0m0.19%
0.19%
Added Shares held: Q3 2025 81.0k, Q4 2025 139.0k, Q1 2026 28.0k, Q2 2026 33.2k
+5.2k
+5,250
18.8%
91
DOXIMITY INC
CL A
DOCS
DOCS
76,107
$1.6m0.15%
0.15%
Reduced Shares held: Q3 2025 136.0k, Q4 2025 372.8k, Q1 2026 183.8k, Q2 2026 76.1k
-107.7k
-107,701
-58.6%
92
PRIVIA HEALTH GROUP INC
COM
PRVA
PRVA
50,000
$1.3m0.12%
0.12%
New Shares held: Q3 2025 194.2k, Q4 2025 125.0k, Q1 2026 0, Q2 2026 50.0k
93
NOVOCURE LTD
ORD SHS
NVCR
NVCR
70,000
$1.1m0.10%
0.10%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 70.0k, Q2 2026 70.0k
94
MINIMED GROUP INC
COM
MMED
MMED
55,000
$822.2k0.08%
0.08%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.0k
95
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
85,000
$735.2k0.07%
0.07%
Added Shares held: Q3 2025 18.0k, Q4 2025 20.0k, Q1 2026 70.0k, Q2 2026 85.0k
+15.0k
+15,000
21.4%
96
AGILON HEALTH INC
COM NEW
AGL
AGL
5,000
$535.9k0.05%
0.05%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.0k
97
10X GENOMICS INC
CL A COM
TXG
TXG
8,500
$325.9k0.03%
0.03%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.5k
98
TANDEM DIABETES CARE INC
COM NEW
TNDM
TNDM
20,000
$301.8k0.03%
0.03%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
99
TG THERAPEUTICS INC
COM
TGTX
TGTX
5,000
$274.7k0.03%
0.03%
New Shares held: Q3 2025 93.0k, Q4 2025 73.2k, Q1 2026 0, Q2 2026 5.0k